Han Yu, Dong Yixin, Jia Bo, Shi Xiangyu, Zhao Hongbo, Li Shushan, Wang Haitao, Sun Binbin, Yin Li, Dai Kerong
Department of Orthopaedics, Medical 3D Printing Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Department of Orthopedic Surgery, Shanghai Key Laboratory of Orthopedic Implants,Clinical and Translational Research Center for 3D Printing Technology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
Mater Today Bio. 2024 Jun 8;27:101114. doi: 10.1016/j.mtbio.2024.101114. eCollection 2024 Aug.
The restoration of cartilage injuries remains a formidable challenge in orthopedics, chiefly attributed to the absence of vascularization and innervation in cartilage. Decellularized extracellular matrix (dECM) derived from cartilage, following antigenic removal through decellularization processes, has exhibited remarkable biocompatibility and bioactivity, rendering it a viable candidate for cartilage repair. Additionally, extracellular vesicles (EVs) generated from cartilage have demonstrated a synergistic effect when combined with dECM, potentially mitigating the inhibitory impact on protein synthesis by phosphorylating 4ebp, thereby promoting the synthesis of cartilage-related proteins such as collagen. In pursuit of this objective, we have innovated a novel bioink and repair scaffold characterized by exceptional biocompatibility, bioactivity, and biodegradability, establishing a tissue-specific microenvironment conducive to chondrogenesis. Within rat osteochondral defects, the biologically active scaffold successfully prompted the formation of transparent cartilage, featuring adequate mechanical strength, favorable elasticity, and dECM deposition indicative of cartilage. In summary, this study has effectively engineered a hydrogel bioink tailored for cartilage repair and devised a bioactive cartilage repair scaffold proficient in instigating cell differentiation and fostering cartilage repair.
软骨损伤的修复在骨科领域仍然是一项艰巨的挑战,主要归因于软骨缺乏血管化和神经支配。通过脱细胞处理去除抗原后,源自软骨的脱细胞细胞外基质(dECM)表现出显著的生物相容性和生物活性,使其成为软骨修复的可行候选材料。此外,软骨产生的细胞外囊泡(EVs)与dECM结合时显示出协同效应,可能通过磷酸化4ebp减轻对蛋白质合成的抑制作用,从而促进胶原蛋白等软骨相关蛋白质的合成。为了实现这一目标,我们创新了一种新型生物墨水和修复支架,其具有卓越的生物相容性、生物活性和生物降解性,建立了有利于软骨形成的组织特异性微环境。在大鼠骨软骨缺损模型中,这种具有生物活性的支架成功促使透明软骨形成,其具有足够的机械强度、良好的弹性以及表明软骨的dECM沉积。总之,本研究有效地设计了一种用于软骨修复的水凝胶生物墨水,并设计了一种能够促进细胞分化和促进软骨修复的生物活性软骨修复支架。